Clinical Trial Update: Maintenance Bee-Venom Immunotherapy Administered at 6-Month Intervals Does Not Protect Against re-Stings [Phase 4]

View source ↗

Summary

A Phase 4 trial found that maintenance bee-venom immunotherapy given every six months did not protect against subsequent bee stings in people with venom allergy…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bee Venom Allergy

Drugs mentioned

• Bee Venom Immunotherapy (bee venom immunotherapy)

Snippet

Sponsor: Meir Medical Center | Conditions: Venom Allergy | Phase 4 | Status: COMPLETED